Across the barrier for tumour imaging

Brain and structure of nanoprobeA probe that can cross the blood-brain barrier to allow high sensitivity brain tumour imaging has been made by Chinese scientists. The probe could be used to pinpoint the location and extent of a tumour before an operation and be used for image-guided tumour removal. 

Establishing the position, extent and structure of brain tumours is crucial for their successful removal. But, current tumour imaging agents used in magnetic resonance imaging are limited by short circulation lifetimes, non-targeted specificity and poor blood-brain barrier permeability. The results of these limitations are that low grade tumours and 20-30 per cent of advanced brain tumours with an intact blood-brain barrier go unnoticed.

Cong Li from Fudan University, Shanghai, and his team made the probe starting with a dendrimer – a branched molecule with a long circulation lifetime – and attached functional groups with different tasks. One such group, a lipoprotein ligand angiopep-2, helps to deliver the probe across the blood-brain barrier and targets the lipoprotein’s receptors, which are present in increased amounts on tumour cells. High-resolution images can be generated thanks to imaging reporters, including fluorescence dyes, attached to the dendrimer. 

Read the rest of this story in Chemistry World and download Li’s ChemComm communication, which is free to access for the rest of the month.

Digg This
Reddit This
Stumble Now!
Share on Facebook
Bookmark this on Delicious
Share on LinkedIn
Bookmark this on Technorati
Post on Twitter
Google Buzz (aka. Google Reader)